MRNA harmonic 886 retracement. Interesting i article I found on the web on retracements. Different pattern but the idea is the same context. "short XA retracement particular, I realized that the B point within a Gartley-type structure that was less than a 0.618 would almost always exceed the expected 0.786 retracement of the XA leg at the projected completion point. I showed Jim this new pattern — called “the Bat” — which used what I was calling a “deep 0.786 retracement.” I told him that executing at the 0.786 without regard to the structure was a critical mistake. Besides, the 0.886 retracement, when used in the correct pattern structures, reduced the amount of risk in previously “undifferentiated” Gartley set-ups by 10 percent."
old.harmonictrader.com
I hope you enjoy the TA.
M1RN34 trade ideas
$MRNA - Head & Shoulders + Double Top continuation baseKey intakes:
- Head & Shoulder Pattern (m).
- Double Top Pattern (w), as the right shoulder of the above.
- No breakout yet to confirm both.
- Are you sure you want to short this market with so much congestion underneath?
- Are you sure you want to go along with so much bearish presence?
- Immaculate example of how an uptrend can be captured with just:
1. A breakout from the IPO base;
2. A 10 EMA (m) trailing the price;
3. A ***tload of discipline and confidence in your system earned through countless hours of chart time, backtesting and a lot of golden teeth.
Moderna at key resistance? Moderna
Short Term
We look to Sell at 183.71 (stop at 203.39)
Preferred trade is to sell into rallies. Previous resistance located at 190.00. Trading within a Bearish Channel formation. Our overall sentiment remains bearish looking for lower levels. The bias is still for lower levels and we look for any gains to be limited.
Our profit targets will be 121.74 and 94.19
Resistance: 190.00 / 220.00 / 495.00
Support: 156.00 / 120.00 / 100.00
Disclaimer – Saxo Bank Group. Please be reminded – you alone are responsible for your trading – both gains and losses. There is a very high degree of risk involved in trading. The technical analysis, like any and all indicators, strategies, columns, articles and other features accessible on/though this site (including those from Signal Centre) are for informational purposes only and should not be construed as investment advice by you. Such technical analysis are believed to be obtained from sources believed to be reliable, but not warrant their respective completeness or accuracy, or warrant any results from the use of the information. Your use of the technical analysis, as would also your use of any and all mentioned indicators, strategies, columns, articles and all other features, is entirely at your own risk and it is your sole responsibility to evaluate the accuracy, completeness and usefulness (including suitability) of the information. You should assess the risk of any trade with your financial adviser and make your own independent decision(s) regarding any tradable products which may be the subject matter of the technical analysis or any of the said indicators, strategies, columns, articles and all other features.
Please also be reminded that if despite the above, any of the said technical analysis (or any of the said indicators, strategies, columns, articles and other features accessible on/through this site) is found to be advisory or a recommendation; and not merely informational in nature, the same is in any event provided with the intention of being for general circulation and availability only. As such it is not intended to and does not form part of any offer or recommendation directed at you specifically, or have any regard to the investment objectives, financial situation or needs of yourself or any other specific person. Before committing to a trade or investment therefore, please seek advice from a financial or other professional adviser regarding the suitability of the product for you and (where available) read the relevant product offer/description documents, including the risk disclosures. If you do not wish to seek such financial advice, please still exercise your mind and consider carefully whether the product is suitable for you because you alone remain responsible for your trading – both gains and losses.
MRNA - Feeling bullish for $200We have seen some solid price movement on MRNA over the past week. We saw pushes past the 180 levels of resistance and now hover within the 190 zone. I am looking for a nice clean break out of $200 to hopefully give us enough legs to get to $210 in the coming weeks. On the daily chart we are coming out of a MACD Cross which is one of my favorite technicals to look at. With news on Monkey Pox as well being a global issue, a stock like this one can see benefits in the coming months as well. Whether I am short or Long I am bullish at this time.
MRNA has rallied 66% from its bottom MRNA has rallied 66% from its bottom set in mid june.
Technical indicators suggest a strong turnaround.
The P/E ratio and Forward P/E ratio remain in the low single digits.
I boosted my position when the price crossed above the 50 day EMA.
I will take advantage of any pull-back below the 200 day EMA close or low.
Overall, this is still a nice entry point if you wish to go long MRNA for the rest of the decade.
8/3/22 MRNAModerna, Inc. ( NASDAQ:MRNA )
Sector: Health Technology (Biotechnology)
Market Capitalization: $74.178B
Current Price: $186.49
Breakout Price: $189.50
Buy Zone (Top/Bottom Range): $180.95-$147.05
Price Target: $204.50-$208.80 (1st), $258.80-$263.70 (2nd)
Estimated Duration to Target: 34-37d, 91-96d
Contract of Interest: $MRNA 9/16/22 190c, $MRNA 10/21/22 200c
Trade price as of publish date: $13.96/contract, $15.55/contract
MRNA early in trend reversalCatalyst may be the federal government's plan to purchase
vaccines for new Covid variants for the fall but then again
purchases from governments on a global basis is further
for future revenues being priced in.
Chart shows trend reversal with crossovers of RSI, MACD
and relative volume.
Is MRNA about to get a fever>
MRNA - SHORT THESISBearish on MRNA, though earnings are always a toss up. If we see a breakout to upside, I believe it's a good short opportunity. Earnings may just flop, and it finds itself testing neckline of weekly H&S, sloppy looking one at that.
Notable areas that could see short term reversals and/or support...
$102, 95, 88, 75